Alcon/ALC

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Alcon

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Ticker

ALC

Sector

Healthcare

Trading on

NYSE

Industry

Health Care Equipment and Supplies

Headquarters

Geneva, Switzerland

Employees

25,000
Website
www.alcon.com

Alcon Metrics

BasicAdvanced
$40B
Market cap
41.75
P/E ratio
$2.11
EPS
0.67
Beta
$0.29
Dividend rate
0.32%
Dividend yield
$40B
0.67
$0.29
2.512
1.432
23.436
24.435
11.07%
5.99%
2.38%
5.15%
41.75
4.54
1.9
13.32
55.92
0.32%
7.68%
205.51%
11.37%
38.25%
36.11%

What the Analysts think about Alcon

Analyst Ratings

Majority rating from 19 analysts.
Buy

Alcon Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
10.08% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$2.5B
4.55%
Net income
$248M
-41.92%
Profit margin
10.08%
-44.46%

Alcon Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 7.03%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.69
$0.66
$0.69
$0.78
-
Expected
$0.64
$0.67
$0.68
$0.73
$0.73
Surprise
7.25%
-1.12%
2.16%
7.03%
-

Alcon News

AllArticlesVideos

Alcon Inc. (ALC) Q1 2024 Earnings Call Transcript

Seeking Alpha·2 months ago

Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health

Business Wire·2 months ago

Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health

Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Alcon stock?

Alcon (ALC) has a market cap of $40B as of July 03, 2024.

What is the P/E ratio for Alcon stock?

The price to earnings (P/E) ratio for Alcon (ALC) stock is 41.75 as of July 03, 2024.

Does Alcon stock pay dividends?

Yes, the Alcon (ALC) stock pays dividends to shareholders. As of July 03, 2024, the dividend rate is $0.28501 and the yield is 0.32%. Alcon has a payout ratio of 11.07% on a trailing twelve-month basis.

When is the next Alcon dividend payment date?

The next Alcon (ALC) dividend payment date is unconfirmed.

What is the beta indicator for Alcon?

Alcon (ALC) has a beta rating of 0.67. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Alcon stock

Buy or sell Alcon stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing